First quarter US GDP was revised from an increase of 0.2% to a contraction of 0.7%. This divergence was attributed to a greater-than-expected trade imbalance as well as lower inventory growth and consumer spending. While early estimates suggest a rebound in second quarter GDP growth in the 3% range, weak consumer spending may constrain such […]
Billerica, MA 5/20/15—Bruker has announced that Executive Vice President and CFO Charles F. Wagner, Jr. will resign effective June 12. He will become CFO of Ortho-Clinical Diagnostics, beginning in late June. “Charlie has been a key architect of our Innovation & Transformation strategy, and has helped Bruker strengthen its leadership, processes and systems,” stated Bruker […]
Brussels, Belgium 5/27/15—Reuters has reported that on May 22, Merck KGaA submitted “commitments” to the EU as to how it will address antitrust concerns raised by its proposed acquisition of Sigma-Aldrich (see IBO 9/30/14). Reuters re-ported that the European Commission now plans to issue a decision regarding the transaction on June 15 instead of June […]
Billerica, MA 5/21/15; Alameda, CA 5/21/15—EMD Millipore, the Life Science division of Merck KGaA, has acquired exclusive rights to Singulex’s Life Science Research business for an undisclosed upfront payment, royalties and milestone payments. Singulex’s SMC (Single Molecule Counting) technology is designed for ultrahigh sensitivity protein detection. “The Erenna platform offers the unique advantage of unrivaled […]
London, UK 5/28/15—Oxford Instruments has entered into a joint venture involving its Omicron Nanotechnology subsidiary and Swedish firm Scienta Scientific, a GD Intressenter business. The combined company will provide highly specialized systems for ultrahigh volume (UHV) surface science. Oxford will hold a 47% share in the joint venture, and GD will hold a 53% share. […]
New Castle, DE 5/26/15—TA Instruments, a Waters subsidiary, has acquired certain assets of Bose ElectroForce from technology firm Bose for an undisclosed amount. Bose ElectroForce manufactures dynamic mechanical testing (DMA) systems used to characterize medical devices, biologics and engineered materials. “[Bose ElectroForce] pioneered the use of electromagnetic motors in scientific instruments. We’re excited to gain […]
Growth for major publicly held instrument and laboratory product businesses stalled in the calendar year first quarter due to glaring currency headwinds and delayed government spending in Japan. For the seven US businesses whose financial results are profiled on page 9, sales contracted 1.8%, as currency and divestments reduced growth by 6.9% and 0.5%, respectively. […]
Expectations for industry growth showed little change compared to last fall (see IBO 10/15/14), according to IBO’s biannual Business Climate Survey. However, compared to a year ago, sentiments were more restrained. This spring, 57% of survey participants expect instrument and laboratory product–industry sales to increase moderately. Forty-three percent expect them to stay the same. However, […]
Pay Invoice
Latest Blogs
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.